BNET Industries
St. Jude Medical Inc. (STJ) is in the Health Care Industry
- Revenue
- Dec 29 2007
- $3.7B
- Profit
- Dec 29 2007
- $559.0M
- Market Cap
- Nov 28 2008
- $9.6B
Latest News and Analysis
St. Jude Medical, Inc. Q3 2008 Earnings Call Transcript
Question-and-Answer Session[Operator Instructions]. Our first question is coming from Bob Hopkins with Banc of America. Robert Hopkins - Banc of America Hi, thank you and good morning. My two questions I would like to refer them to John. Just to clarify some of the comments that were made. John,...
Zacks Analyst Blog Highlights: St. Jude Medical, Inc., Carmike Cinemas, Inc., The Washington Post Co., Avis Budget Group Inc. and Robert Half International Inc
CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: St. Jude Medical, Inc. (NYSE: STJ), Carmike Cinemas, Inc. (Nasdaq: CKEC),...
Zacks Bull and Bear of the Day Highlights: St. Jude Medical, AAR Corp., Sangamo Biosciences, State Auto Financial and Robert Half
CHICAGO -- Zacks Equity Research highlights St. Jude Medical (NYSE: STJ) as the Bull of the Day and AAR Corporation (NYSE: AIR) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Sangamo Biosciences, Inc. (Nasdaq: SGMO), State Auto Financial Corporation (Nasdaq: STFC) and Robert Half...
St. Jude Medical To Present at Morgan Stanley Global Healthcare Unplugged Conference
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) will present at the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, Sept. 9, in New York City. John Heinmiller, executive vice president and chief financial officer, will address the conference at 11:30 a.m. EDT. The presentation will also be Web...
Revisions Ratios Help Uncover Hidden Gems
Zacks.com submits: Our Director of Zacks Equity Research Dirk van Dijk, CFA slices and dices all sorts of data on publicly traded industries. Recently, we got his take on something called a “revisions ratio,” and managed to get a few Buy recommendations in the process. You track...
IHI: Medical Devices Make a Momentum Comeback
Don Dion submits: In the last few months of tough stock-market sledding, one of the tried-and-true axioms of investing has come to the forefront: The health care sector is a good place to hide during bear markets. Over the last three months (through Aug. 8), seven funds...
St. Jude Medical: Safety in a Wild Market
Joshua Hayes submits: In a market where investing can be very dangerous, there are very few options to go to where one can be safe. Well, just like being in some horrible accident, in the stock market you can always find relief in medical stocks. Obviously, some stand out compared...
St. Jude Medical, Inc. Q2 2008 Earnings Call Transcript
Question-and-Answer SessionThank you. [Operator Instructions]. Your first question is from Bob Hopkins [ph] with Banc of America. Please go ahead. Unidentified Analyst Thanks [ph] and good morning and congrats on the results. Daniel J. Starks - Chairman, President and Chief Executive Officer Good morning Bob. Unidentified Analyst I have...
St. Jude Medical Announces CE Mark Approval and European Launch of TigerWire Steerable Guidewire
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE: STJ) today announced European CE Mark approval and the European launch of the TigerWire[TM] Steerable Guidewire. The announcement was made in Barcelona, Spain, at EuroPCR 2008, a premiere scientific and professional event for cardiologists, vascular surgeons and other medical specialists who...
Research and Markets: Analysis of St. Jude Medical, Inc. Provides a Comprehensive Insight into This Company
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c92582) has announced the addition of "Analysis of St. Jude Medical, Inc." to their offering.
St. Jude Medical Announces Launch of New Circular Mapping Catheter
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced the U.S. launch of the Reflexion Spiral X[TM] variable radius mapping catheter at Heart Rhythm 2008. This new catheter will provide physicians with greater maneuverability, stability and control when used in the left atrium for the mapping of abnormal...
St. Jude Medical Announces Start of Landmark DETERMINE ICD Study
Clinical trial will investigate effectiveness of implantable cardioverter defibrillator therapy in heart attack patients
St. Jude Medical Announces the Release of EnSite System Version 8.0 Software
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced the release of its EnSite[TM] System Version 8.0 software. The new software will help physicians more intuitively visualize the anatomy of the heart to diagnose and treat abnormal heart rhythms. St. Jude Medical will feature the EnSite v.8.0 at...
St. Jude Medical Announces FDA Approval of Next-Generation Remote Monitoring and Data Management System for Implantable Cardiac Devices
Merlin.net Patient Care Network contacts patients with automated interactive voice response system
St. Jude Medical Announces Results of Shareholders' Vote at Annual Meeting
ST. PAUL, Minn. -- Second paragraph should read: In addition, shareholders approved certain amendments to the St. Jude Medical, Inc. 2007 Stock Incentive Plan, ratified the appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm, and approved an amendment to the articles of incorporation to...
St. Jude Medical to Launch New Brand Identity
The new brand identity will combine the company's commitment to meeting customer needs with its reputation for quality
St. Jude Medical Announces FDA Clearance and CE Mark Approval of Strada Carotid Guiding Sheath
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration FDA clearance and European CE Mark approval of the Strada[TM] Carotid Guiding Sheath, a flexible tube through which physicians can deliver balloon catheters, stents and other tools to open blockages in the carotid arteries....
St. Jude Medical Announces U.S. Launch of TigerWire Steerable Guidewire
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. launch of the TigerWire[TM] Steerable Guidewire. The newest member of the St. Jude Medical GuideRight[TM] family of steerable guidewires, the TigerWire Steerable Guidewire is designed to enhance physicians' ability to steer through challenging peripheral arteries, the vessels that...
St. Jude Medical to Present at Morgan Stanley Global Healthcare Unplugged Conference
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) will present at the Morgan Stanley Global Healthcare Unplugged Conference on Wednesday, April 30, 2008, in Key Biscayne, FL. Dan Starks, Chairman, President & Chief Executive Officer, will address the conference at 3:40 p.m. ET. The presentation will also be web...
St. Jude Medical Awarded U.S. Patent for Neurostimulation Therapy for Depression
Brodmann Area 25 Study Moves Forward With Enrollment of First Patient
- Next »
- page 1 of 20
- « Previous
Sort byClose
View by Content TypeClose
View Related Content by Tag Close
- FDA (27 results)
- Company (16 results)
- Patient (15 results)
- health care (13 results)
- stock (13 results)
- agreement (12 results)
- software (10 results)
- S&P 500 (8 results)
- clinical trial (7 results)
- Microsoft Windows CE (7 results)
- Finance (7 results)
- therapy (6 results)
- shareholder (6 results)
- Investment (6 results)
- board of directors (6 results)
- MARKETING (6 results)
- board (5 results)
- physician (5 results)
- HEALTHCARE (4 results)
- Nasdaq Stock Market Inc. (4 results)
- New York Stock Exchange (4 results)
- Epicor Software Corp. (4 results)
- Morgan Stanley (4 results)
- acquisition (4 results)
- Boston Scientific Corp. (4 results)
- sales (4 results)
- EPIC (4 results)
- medical device (4 results)
- Bear Stearns & Co. Inc. (3 results)
- class action (3 results)
- tool (3 results)
- Atlas (3 results)
- IDE (3 results)
- CRM (3 results)
- conference (3 results)
- Medtronic Inc. (3 results)
- Incorporated: 1976
- CEO: Mr. Daniel J. Starks
St. Jude Medical develops, manufactures and distributes cardiovascular medical devices for the cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and implantable neurostimulation devices for chronic pain management. Co. has four operating segments with principal products including: Cardiac Rhythm Management segment: tachycardia implantable cardioverter defibrillator systems and bradycardia pacemaker systems; Cardiovascular segment: vascular closure devices and heart valve replacement and repair products; Atrial Fibrillation segment: electrophysiology introducers and catheters; and Advanced Neuromodulation Systems segment: neurostimulation devices.
Key Competitors
Industry Transcripts by Seeking Alpha
-
Landauer, Inc. F4Q08 (Qtr End 9/30/08) Earnings Call Transcript
on Dec 02, 2008about LDR
-
Landauer, Inc. F4Q08 (Qtr End 9/30/08) Earnings Call Transcript
on Dec 02, 2008about LDR
-
Thermage Inc. Q3 2008 Earnings Call Transcript
on Dec 01, 2008about THRM
-
Allied Healthcare International Inc. F4Q08 (Qtr End 09/30/08) Earnings Call Transcript
on Nov 25, 2008about AHCI
-
StoneMor Partners, LP Q3 2008 (Quarter End 9/30/08) Earnings Call Transcript
on Nov 25, 2008about STON
St. Jude Medical Inc. Company Info
Board of Directors
Mr. Daniel J. Starks
Chairman
Mr. Richard R. Devenuti
Dr. Stuart M. Essig Ph.D.
Mr. Thomas H. Garrett III
Ms. Wendy L. Yarno
Mr. John W. Brown
Mr. Barbara B. Hill
Mr. Michael A. Rocca
Mr. Stephan K. Widensohler
Contact Information
One Lillehei Plaza
St. Paul, MN
1 651 483-2000
NAICS Code
Electromedical and Electrotherapeutic Apparatus Manufacturing: 334510
